{"id":"https://openalex.org/W7214903073","doi":"https://doi.org/10.3389/fneur.2026.1943801","title":"NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives","display_name":"NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives","publication_year":2026,"publication_date":"2026-09-30","ids":{"openalex":"https://openalex.org/W7214903073","doi":"https://doi.org/10.3389/fneur.2026.1943801","pmid":"https://pubmed.ncbi.nlm.nih.gov/42877680","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13663023"},"language":"en","primary_location":{"id":"doi:10.3389/fneur.2026.1943801","doi":"https://doi.org/10.3389/fneur.2026.1943801","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1943801","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1943801/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1943801/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153667589","display_name":"Tianbao Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tianbao Wang","raw_affiliation_strings":["Tianbao Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianbao Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153656951","display_name":"Xue Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154093214","display_name":"Xinjiang Medical University","ror":"https://ror.org/01p455v08","country_code":"CN","type":"education","lineage":["https://openalex.org/I154093214"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xue Zhou","raw_affiliation_strings":["Xinjiang Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xinjiang Medical University","institution_ids":["https://openalex.org/I154093214"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5135508329","display_name":"Xinhua Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141161","display_name":"The Affiliated Hospital to Changchun University of Chinese Medicine","ror":"https://ror.org/03ksg3960","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210141161"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xinhua Chen","raw_affiliation_strings":["The Affiliated Hospital to Changchun University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Affiliated Hospital to Changchun University of Chinese Medicine","institution_ids":["https://openalex.org/I4210141161"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5135508329"],"corresponding_institution_ids":["https://openalex.org/I4210141161"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.5484019,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1943801","last_page":"1943801"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.7621999979019165,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.7621999979019165,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":0.1923999935388565,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.03420000150799751,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9909999966621399},{"id":"https://openalex.org/keywords/nad-signaling","display_name":"NAD+ signaling","score":0.9520000219345093},{"id":"https://openalex.org/keywords/nad-precursors","display_name":"NAD+ precursors","score":0.9240000247955322},{"id":"https://openalex.org/keywords/nicotinamide-riboside","display_name":"nicotinamide riboside","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nicotinamide-mononucleotide","display_name":"nicotinamide mononucleotide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mitochondrial-unfolded-protein-response","display_name":"mitochondrial unfolded protein response","score":0.8370000123977661},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.9599999785423279},{"id":"https://openalex.org/keywords/mitochondrial-quality-control","display_name":"mitochondrial quality control","score":0.8149999976158142},{"id":"https://openalex.org/keywords/proteostasis","display_name":"proteostasis","score":0.8669999837875366},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/alpha-synuclein","display_name":"alpha-synuclein","score":0.8489999771118164},{"id":"https://openalex.org/keywords/dopaminergic-neuron-degeneration","display_name":"dopaminergic neuron loss","score":0.8799999952316284},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7990000247955322},{"id":"https://openalex.org/keywords/nad-supplementation","display_name":"NAD+ supplementation","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C75520062","wikidata":"https://www.wikidata.org/wiki/Q15321392","display_name":"NAD+ kinase","level":3,"score":0.8611999750137329},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.7457000017166138},{"id":"https://openalex.org/C2777088662","wikidata":"https://www.wikidata.org/wiki/Q21547155","display_name":"Nicotinamide mononucleotide","level":5,"score":0.5855000019073486},{"id":"https://openalex.org/C2776901170","wikidata":"https://www.wikidata.org/wiki/Q12499775","display_name":"Nicotinamide adenine dinucleotide","level":4,"score":0.5637999773025513},{"id":"https://openalex.org/C2780561631","wikidata":"https://www.wikidata.org/wiki/Q421331","display_name":"Sirtuin","level":4,"score":0.5371999740600586},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5203999876976013},{"id":"https://openalex.org/C28859421","wikidata":"https://www.wikidata.org/wiki/Q39572","display_name":"Mitochondrion","level":2,"score":0.5077000260353088},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.44110000133514404},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4372999966144562},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.42989999055862427},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.41530001163482666},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.3901999890804291},{"id":"https://openalex.org/C2780391879","wikidata":"https://www.wikidata.org/wiki/Q18035058","display_name":"Nicotinamide phosphoribosyltransferase","level":4,"score":0.3824000060558319},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.37310001254081726},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3720000088214874},{"id":"https://openalex.org/C2779728014","wikidata":"https://www.wikidata.org/wiki/Q192423","display_name":"Nicotinamide","level":3,"score":0.3662000000476837},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.35580000281333923},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.35350000858306885},{"id":"https://openalex.org/C197957613","wikidata":"https://www.wikidata.org/wiki/Q407280","display_name":"Cofactor","level":3,"score":0.32679998874664307},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3075999915599823},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.3050999939441681},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.3043000102043152},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.29750001430511475},{"id":"https://openalex.org/C24586158","wikidata":"https://www.wikidata.org/wiki/Q27075","display_name":"Mitochondrial DNA","level":3,"score":0.29030001163482666},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29030001163482666},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.2799000144004822},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2624000012874603},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25130000710487366}],"mesh":[{"descriptor_ui":"D000090862","descriptor_name":"Neuroinflammatory Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009243","descriptor_name":"NAD","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fneur.2026.1943801","doi":"https://doi.org/10.3389/fneur.2026.1943801","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1943801","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1943801/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13663023","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13663023/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13663023/pdf/fneur-17-1943801.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Neurol","raw_type":"Text"},{"id":"pmid:42877680","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42877680","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in neurology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c15e0d81b4e94c0e85548b50142d2ae2","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c15e0d81b4e94c0e85548b50142d2ae2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Neurology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fneur.2026.1943801","doi":"https://doi.org/10.3389/fneur.2026.1943801","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1943801","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1943801/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214903073.pdf","grobid_xml":"https://content.openalex.org/works/W7214903073.grobid-xml"},"referenced_works_count":69,"referenced_works":["https://openalex.org/W1504661786","https://openalex.org/W1537703810","https://openalex.org/W1973506787","https://openalex.org/W1975163591","https://openalex.org/W2012043504","https://openalex.org/W2068128334","https://openalex.org/W2069623008","https://openalex.org/W2076252987","https://openalex.org/W2083619889","https://openalex.org/W2085596919","https://openalex.org/W2090053747","https://openalex.org/W2093048027","https://openalex.org/W2095603792","https://openalex.org/W2097478351","https://openalex.org/W2102614059","https://openalex.org/W2108536847","https://openalex.org/W2174179366","https://openalex.org/W2284984697","https://openalex.org/W2301709882","https://openalex.org/W2399338035","https://openalex.org/W2524246096","https://openalex.org/W2559832518","https://openalex.org/W2561342425","https://openalex.org/W2598007332","https://openalex.org/W2618669287","https://openalex.org/W2743027547","https://openalex.org/W2782101574","https://openalex.org/W2805234895","https://openalex.org/W2806958861","https://openalex.org/W2809421568","https://openalex.org/W2897422184","https://openalex.org/W2915556067","https://openalex.org/W2919568651","https://openalex.org/W2951321658","https://openalex.org/W2971344816","https://openalex.org/W2983743725","https://openalex.org/W3044950861","https://openalex.org/W3088336143","https://openalex.org/W3115773653","https://openalex.org/W3171702175","https://openalex.org/W3198479934","https://openalex.org/W3208396381","https://openalex.org/W4214529012","https://openalex.org/W4223422426","https://openalex.org/W4226179888","https://openalex.org/W4309737317","https://openalex.org/W4309771880","https://openalex.org/W4311636721","https://openalex.org/W4319295182","https://openalex.org/W4320729216","https://openalex.org/W4322505054","https://openalex.org/W4323266817","https://openalex.org/W4366742757","https://openalex.org/W4377115354","https://openalex.org/W4388625945","https://openalex.org/W4389092885","https://openalex.org/W4391124253","https://openalex.org/W4391644301","https://openalex.org/W4393949126","https://openalex.org/W4395012503","https://openalex.org/W4399916108","https://openalex.org/W4399981565","https://openalex.org/W4400450368","https://openalex.org/W4403978169","https://openalex.org/W4405747088","https://openalex.org/W4412507894","https://openalex.org/W4412706619","https://openalex.org/W4416730426","https://openalex.org/W7165371254"],"related_works":["https://openalex.org/W4408650268","https://openalex.org/W7117771479","https://openalex.org/W4289705421","https://openalex.org/W3163466832","https://openalex.org/W4412507894","https://openalex.org/W4214529012","https://openalex.org/W2805234895","https://openalex.org/W3022699787","https://openalex.org/W4386982924","https://openalex.org/W4233153472"],"abstract_inverted_index":{"Parkinson's":[0],"disease":[1],"(PD)":[2],"is":[3,54],"the":[4,13,20,58,91,112,120,128],"second":[5],"most":[6],"prevalent":[7],"neurodegenerative":[8],"disorder":[9],"worldwide,":[10],"characterized":[11],"by":[12],"progressive":[14],"loss":[15],"of":[16,24,60,90,98,102,115,122],"dopaminergic":[17],"neurons":[18],"in":[19,41,57,119,145,150],"substantia":[21],"nigra,":[22],"accumulation":[23],"\u03b1-synuclein":[25],"(\u03b1-syn),":[26],"mitochondrial":[27,92,134],"dysfunction,":[28],"and":[29,47,53,77,100,138,153],"neuroinflammation.":[30,139],"Nicotinamide":[31],"adenine":[32],"dinucleotide":[33],"(NAD":[34],"+":[35,71,117,132,147],"),":[36],"a":[37],"crucial":[38],"coenzyme":[39],"involved":[40],"cellular":[42],"energy":[43],"metabolism,":[44],"DNA":[45],"repair,":[46],"epigenetic":[48],"regulation,":[49],"declines":[50],"with":[51,62,69,124],"aging":[52],"markedly":[55],"reduced":[56],"brains":[59],"patients":[61],"PD.":[63],"Emerging":[64],"evidence":[65],"suggests":[66],"that":[67],"supplementation":[68],"NAD":[70,116,131,146],"precursors,":[72],"including":[73],"nicotinamide":[74,78],"riboside":[75],"(NR)":[76],"mononucleotide":[79],"(NMN),":[80],"exerts":[81],"neuroprotective":[82],"effects":[83],"through":[84],"multiple":[85],"mechanisms,":[86],"such":[87],"as":[88],"activation":[89],"unfolded":[93],"protein":[94],"response":[95],"(UPR\u2227mt),":[96],"enhancement":[97],"autophagy,":[99],"suppression":[101],"excessive":[103],"poly(ADP-ribose)":[104],"polymerase":[105],"1":[106],"(PARP1)":[107],"activation.":[108],"This":[109],"review":[110],"summarizes":[111],"central":[113],"role":[114],"dysregulation":[118],"pathogenesis":[121],"PD,":[123],"particular":[125],"emphasis":[126],"on":[127],"interplay":[129],"between":[130],"depletion,":[133],"quality":[135],"control,":[136],"proteostasis,":[137],"Furthermore,":[140],"we":[141],"discuss":[142],"recent":[143],"advances":[144],"-boosting":[148],"strategies":[149],"PD":[151,162],"models":[152],"clinical":[154],"studies,":[155],"highlighting":[156],"their":[157],"potential":[158],"therapeutic":[159],"implications":[160],"for":[161],"intervention.":[163]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-01T00:00:00"}